Biotechnology Fund Investor Fund Last Dividend Paid
| RYOIX Fund | USD 78.05 10.66 15.82% |
Biotechnology Fund Investor fundamentals help investors to digest information that contributes to Biotechnology Fund's financial success or failures. It also enables traders to predict the movement of Biotechnology Mutual Fund. The fundamental analysis module provides a way to measure Biotechnology Fund's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotechnology Fund mutual fund.
Biotechnology |
Biotechnology Fund Investor Mutual Fund Last Dividend Paid Analysis
Biotechnology Fund's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, Biotechnology Fund Investor has a Last Dividend Paid of 0.0. This indicator is about the same for the Rydex Funds average (which is currently at 0.0) family and about the same as Health (which currently averages 0.0) category. This indicator is about the same for all United States funds average (which is currently at 0.0).
Biotechnology Last Dividend Paid Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biotechnology Fund's direct or indirect competition against its Last Dividend Paid to detect undervalued stocks with similar characteristics or determine the mutual funds which would be a good addition to a portfolio. Peer analysis of Biotechnology Fund could also be used in its relative valuation, which is a method of valuing Biotechnology Fund by comparing valuation metrics of similar companies.Biotechnology Fund is currently under evaluation in last dividend paid among similar funds.
Fund Asset Allocation for Biotechnology Fund
The fund invests 99.51% of asset under management in tradable equity instruments, with the rest of investments concentrated in cash (0.95%) .Asset allocation divides Biotechnology Fund's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
Biotechnology Fundamentals
| Price To Earning | 19.47 X | ||||
| Price To Book | 3.69 X | ||||
| Price To Sales | 4.99 X | ||||
| Total Asset | 94.38 M | ||||
| Year To Date Return | 2.85 % | ||||
| One Year Return | 7.15 % | ||||
| Three Year Return | (1.14) % | ||||
| Five Year Return | 3.31 % | ||||
| Ten Year Return | 17.61 % | ||||
| Net Asset | 117.21 M | ||||
| Cash Position Weight | 0.95 % | ||||
| Equity Positions Weight | 99.51 % |
About Biotechnology Fund Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotechnology Fund Investor's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotechnology Fund using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotechnology Fund Investor based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Fund financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Fund security.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |